1-7 of 7
Mark C. Willingham
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model

Free
Xuguang Zhu, Keisuke Enomoto, Li Zhao, Yuelin J. Zhu, Mark C. Willingham, Paul Meltzer, Jun Qi, Sheue-yann Cheng
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (2): 430–440.
https://doi.org/10.1158/1078-0432.CCR-16-0914
Published: 15 January 2017
View articletitled, Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model
Open the PDF for Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model in another window
Includes: Supplementary data
Journal Articles

SKI-606, an Src Inhibitor, Reduces Tumor Growth, Invasion, and Distant Metastasis in a Mouse Model of Thyroid Cancer

Free
Won Gu Kim, Celine J. Guigon, Laura Fozzatti, Jeong Won Park, Changxue Lu, Mark C. Willingham, Sheue-yann Cheng
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (5): 1281–1290.
https://doi.org/10.1158/1078-0432.CCR-11-2892
Published: 01 March 2012
View articletitled, SKI-606, an Src Inhibitor, Reduces Tumor Growth, Invasion, and Distant Metastasis in a Mouse Model of Thyroid Cancer
Open the PDF for SKI-606, an Src Inhibitor, Reduces Tumor Growth, Invasion, and Distant Metastasis in a Mouse Model of Thyroid Cancer in another window
Journal Articles

Phase I Study of SS1P, a Recombinant Anti-Mesothelin Immunotoxin Given as a Bolus I.V. Infusion to Patients with Mesothelin-Expressing Mesothelioma, Ovarian, and Pancreatic Cancers

Free
Raffit Hassan, Susie Bullock, Ahalya Premkumar, Robert J. Kreitman, Hedy Kindler, Mark C. Willingham, Ira Pastan
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (17): 5144–5149.
https://doi.org/10.1158/1078-0432.CCR-07-0869
Published: 04 September 2007
View articletitled, Phase I Study of SS1P, a Recombinant Anti-Mesothelin Immunotoxin Given as a Bolus I.V. Infusion to Patients with Mesothelin-Expressing Mesothelioma, Ovarian, and Pancreatic Cancers
Open the PDF for Phase I Study of SS1P, a Recombinant Anti-Mesothelin Immunotoxin Given as a Bolus I.V. Infusion to Patients with Mesothelin-Expressing Mesothelioma, Ovarian, and Pancreatic Cancers in another window
Journal Articles

Mesothelin Expression in Human Lung Cancer

Free
Mitchell Ho, Tapan K. Bera, Mark C. Willingham, Masanori Onda, Raffit Hassan, David FitzGerald, Ira Pastan
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (5): 1571–1575.
https://doi.org/10.1158/1078-0432.CCR-06-2161
Published: 01 March 2007
View articletitled, Mesothelin Expression in Human Lung Cancer
Open the PDF for Mesothelin Expression in Human Lung Cancer in another window
Journal Articles

Interstitial Diphtheria Toxin-Epidermal Growth Factor Fusion Protein Therapy Produces Regressions of Subcutaneous Human Glioblastoma Multiforme Tumors in Athymic Nude Mice

Free
Tie Fu Liu, Philip D. Hall, Kimberley A. Cohen, Mark C. Willingham, Jiaozhong Cai, Andrew Thorburn, Arthur E. Frankel
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 329–334.
https://doi.org/10.1158/1078-0432.329.11.1
Published: 21 January 2005
View articletitled, Interstitial Diphtheria Toxin-Epidermal Growth Factor Fusion Protein Therapy Produces Regressions of Subcutaneous Human Glioblastoma Multiforme Tumors in Athymic Nude Mice
Open the PDF for Interstitial Diphtheria Toxin-Epidermal Growth Factor Fusion Protein Therapy Produces Regressions of Subcutaneous Human Glioblastoma Multiforme Tumors in Athymic Nude Mice in another window
Journal Articles

Imaging and Phase I Study of 111In- and 90Y-labeled Anti-LewisY Monoclonal Antibody B3

Free
Lee H. Pai-Scherf, Jorge A. Carrasquillo, Chang Paik, Otto Gansow, Millie Whatley, Deb Pearson, Keith Webber, Michael Hamilton, Carmen Allegra, Martin Brechbiel, Mark C. Willingham, Ira Pastan
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (5): 1720–1730.
Published: 01 May 2000
View articletitled, Imaging and Phase I Study of 111In- and 90Y-labeled Anti-LewisY Monoclonal Antibody B3
Open the PDF for Imaging and Phase I Study of 111In- and 90Y-labeled Anti-LewisY Monoclonal Antibody B3 in another window
Journal Articles

Hepatotoxicity in Cancer Patients Receiving erb-38, a Recombinant Immunotoxin That Targets the erbB2 Receptor

Free
Lee H. Pai-Scherf, Jacy Villa, Deborah Pearson, Thelma Watson, Edison Liu, Mark C. Willingham, Ira Pastan
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2311–2315.
Published: 01 September 1999
View articletitled, Hepatotoxicity in Cancer Patients Receiving erb-38, a Recombinant Immunotoxin That Targets the erbB2 Receptor
Open the PDF for Hepatotoxicity in Cancer Patients Receiving erb-38, a Recombinant Immunotoxin That Targets the erbB2 Receptor in another window